Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
Roussot N, Fumet JD, Limagne E, Thibaudin M, Hervieu A, Hennequin A, Zanetta S, Dalens L, Fourrier T, Galland L, Jacob P, Bertaut A, Rederstorff E, Chevalier C, Ghirardi S, Gilbert E, Khoukaz A, Martin E, Nicolet C, Quivrin M, Thibouw D, Vulquin N, Truc G, Rouffiac M, Ghiringhelli F, Mirjolet C. Roussot N, et al. Among authors: rouffiac m. BMC Cancer. 2023 Nov 9;23(1):1080. doi: 10.1186/s12885-023-11534-6. BMC Cancer. 2023. PMID: 37946136 Free PMC article. Clinical Trial.
Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.
Kada Mohammed S, Dabakuyo Yonli TS, Desmoulins I, Manguem Kamga A, Jankowski C, Padeano MM, Loustalot C, Costaz H, Causeret S, Peignaux K, Rouffiac M, Coutant C, Arnould L, Ladoire S. Kada Mohammed S, et al. Among authors: rouffiac m. Breast Cancer Res Treat. 2023 Jan;197(2):377-385. doi: 10.1007/s10549-022-06807-w. Epub 2022 Nov 23. Breast Cancer Res Treat. 2023. PMID: 36417042 Free PMC article.
Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
Costaz H, Boulle D, Bertaut A, Rouffiac M, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Causeret S, Loustalot C, Padeano MM, Vincent L, Jankowski C, Arnould L, Coutant C. Costaz H, et al. Among authors: rouffiac m. Bull Cancer. 2022 Mar;109(3):268-279. doi: 10.1016/j.bulcan.2021.09.018. Epub 2021 Nov 24. Bull Cancer. 2022. PMID: 34838310
[Extreme hypofractionated radiation therapy for pancreatic cancer].
Rouffiac M, Ghirardi S, Chevalier C, Bessières I, Peignaux-Casasnovas K, Truc G, Créhange G. Rouffiac M, et al. Cancer Radiother. 2021 Oct;25(6-7):692-698. doi: 10.1016/j.canrad.2021.06.031. Epub 2021 Jul 17. Cancer Radiother. 2021. PMID: 34284971 Review. French.
[Para-aortic lymph node staging in grade IB2 and above cervical cancers: Comparison of 18FDG PET-CT with para-aortic lymphadenectomy, using data from the Côte d'Or gynaecological cancer registry from 2003 to 2016].
Carré A, Sellier J, Kamga AM, Dabakuyo S, Rouffiac M, Coutant C. Carré A, et al. Among authors: rouffiac m. Gynecol Obstet Fertil Senol. 2021 Sep;49(9):677-683. doi: 10.1016/j.gofs.2021.01.013. Epub 2021 Jan 20. Gynecol Obstet Fertil Senol. 2021. PMID: 33484900 French.
[Strategies in case of metastatic sentinel lymph node in breast cancer].
Costaz H, Rouffiac M, Boulle D, Arnould L, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Vincent L, Jankowski C, Coutant C. Costaz H, et al. Among authors: rouffiac m. Bull Cancer. 2020 Jun;107(6):672-685. doi: 10.1016/j.bulcan.2019.09.005. Epub 2019 Nov 4. Bull Cancer. 2020. PMID: 31699399 Review. French.